29
/
en
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
April 1, 2024
101424
9226
1

mar 28, 2014 - Elelyso licensed for Type 3 Gaucher disease in Canada, specifically for hematologic manifestations in pediatric patients

Added to timeline:

4 Oct 2017
0
0
609
New timeline
All

Date:

mar 28, 2014
Now
~ 10 years ago
PremiumAbout & FeedbackTermsPrivacy
logo
© 2022 Selected Technologies LLC – Morgan Hill, California